Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-021068
Filing Date
2024-02-13
Accepted
2024-02-13 17:06:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv01066-halozymetherapeutics.htm SC 13G/A 11480
  Complete submission text file 0001104659-24-021068.txt   13250
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Subject) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-78830 | Film No.: 24628511
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)